won’t need to wait ten years…with 3 ongoing Phase 1b clinical trials and phase 1 for this exciting chm 2101 therapy, we are only months away from interim data read outs. We are already in the sweet spot for M&A with big pharma.
Chimeric: Media Thread, page-681
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable